| Product Code: ETC9615939 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Celiac Disease Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Celiac Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Celiac Disease Market - Industry Life Cycle |
3.4 Taiwan Celiac Disease Market - Porter's Five Forces |
3.5 Taiwan Celiac Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Taiwan Celiac Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Taiwan Celiac Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Taiwan Celiac Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Celiac Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about celiac disease and gluten-free diets in Taiwan |
4.2.2 Growing prevalence of celiac disease in the Taiwanese population |
4.2.3 Rise in demand for gluten-free products and alternatives in the market |
4.3 Market Restraints |
4.3.1 Limited availability of specialized gluten-free products in Taiwan |
4.3.2 High cost associated with gluten-free products compared to regular food items |
5 Taiwan Celiac Disease Market Trends |
6 Taiwan Celiac Disease Market, By Types |
6.1 Taiwan Celiac Disease Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Celiac Disease Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Taiwan Celiac Disease Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.1.4 Taiwan Celiac Disease Market Revenues & Volume, By Larazotide Acetate, 2021- 2031F |
6.1.5 Taiwan Celiac Disease Market Revenues & Volume, By Gluten Free Diet, 2021- 2031F |
6.1.6 Taiwan Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Celiac Disease Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Celiac Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Taiwan Celiac Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Taiwan Celiac Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Celiac Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Taiwan Celiac Disease Market Revenues & Volume, By homecare, 2021- 2031F |
6.3.4 Taiwan Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Taiwan Celiac Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Celiac Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Taiwan Celiac Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Taiwan Celiac Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Taiwan Celiac Disease Market Import-Export Trade Statistics |
7.1 Taiwan Celiac Disease Market Export to Major Countries |
7.2 Taiwan Celiac Disease Market Imports from Major Countries |
8 Taiwan Celiac Disease Market Key Performance Indicators |
8.1 Number of celiac disease diagnoses in Taiwan |
8.2 Percentage increase in gluten-free product sales |
8.3 Adoption rate of gluten-free diet among the Taiwanese population |
9 Taiwan Celiac Disease Market - Opportunity Assessment |
9.1 Taiwan Celiac Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Taiwan Celiac Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Taiwan Celiac Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Taiwan Celiac Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Celiac Disease Market - Competitive Landscape |
10.1 Taiwan Celiac Disease Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Celiac Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |